Obama Thinks "Precision Medicine" Will Make Us Healthier. Experts are Skeptical.
By Julia Belluz,
Vox
| 01. 30. 2015
Untitled Document
The White House is committing $215 million to support efforts to develop personalized medicine, a priority the President touched on in his State of the Union earlier this month.
At the time, the details weren't clear. But today the White House released more information on the "precision medicine initiative," which has bipartisan support: it would get started with a $215 million cash injection from the 2016 federal budget to support everything from the building databases at the National Institutes of Health to study the genetic bases of disease, to applying that knowledge to targeted cancer therapeutics and public health.
"Most medical treatments have been designed for the 'average patient,'" the White House statement read. "As a result of this 'one-size-fits-all-approach,' treatments can be very successful for some patients but not for others."
The only problem is that this is much, much harder than it sounds.
Precision medicine — also known as personalized or individualized medicine — has been one of the big, unmet promises in health care for a long time. Hank Greely, a law professor at Stanford...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...
